Modulated vs Fixed-Frequency EMS, What the Evidence Supports
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
Some electrical stimulation holds one frequency for the whole session and some varies it continuously, and the difference has real research behind it.
This article compares the two on what decides the result you actually see, such as:
- What fixed frequency does
- What varying it changes
- The limits of the evidence
- What PDM actually varies
- What matters more than modulation
and many more!
Here is what varying frequency actually does, what the studies measured, and how far that finding can honestly be carried onto a face.
Key Points:
A fixed frequency recruits much the same fibres in much the same order for the whole session, and fatigue builds accordingly.
Varying frequency is supported in the general literature as a way to delay the onset of that fatigue.
Most of the underlying work was done on limb muscle, not on the face.
PDM varies frequency across 361 points between 1,370 and 1,730 Hz, and varies nothing else.
No head-to-head trial has compared a modulated facial device against a fixed-frequency one, so nobody can honestly claim a proven advantage.
What fixed frequency does
A stimulator holding a constant frequency delivers a repetitive, unchanging signal, and muscle responds to that signal in a fairly predictable way.
Because the pattern does not change, broadly the same motor units are recruited in broadly the same sequence throughout, and those units carry the load without relief.
Fatigue during electrical stimulation sets in faster than during voluntary movement, partly because your nervous system rotates recruitment during voluntary effort and a fixed electrical signal does not.
The practical result is a contraction that weakens as the session goes on while the dial has not moved.
What varying it changes
Changing frequency during a session alters the recruitment pattern, which spreads the work rather than concentrating it on the same units for the whole ten minutes.
The literature on this is about delaying the onset of fatigue, and delaying fatigue is a modest, specific and genuinely useful claim.
It is not a claim that modulated stimulation builds more muscle, produces a better result, or reaches deeper tissue, and those three are the versions you will see on competitor pages.
A comfortable session that stays consistent to the end is worth having on its own, and it does not need to be inflated into something else.
The limits of the evidence
Most of the fatigue research was done on limb muscle under laboratory conditions, using output levels and electrode arrangements unlike anything a home facial device uses.
Facial muscles are smaller, thinner, and attach to skin rather than to a second bone, so carrying a limb finding straight onto a face is an assumption rather than a measurement.
The honest position is that modulation is well supported as a principle and untested as a facial comparison, which is why PureLift describes PDM as an engineering approach rather than a proven advantage.
What PDM actually varies
PDM continuously varies the stimulation frequency across 361 distinct points between 1,370 and 1,730 Hz.
Frequency is the only quantity it changes, amplitude stays where you set it and pulse duration stays where the device sets it, and saying so plainly matters because the supporting literature is specifically about frequency variation.
Any description of PDM that adds a second or third simultaneous component, or that assigns different frequencies to different tissue depths, is describing something the architecture does not do.
PDM runs on all five PureLift models, from Face at $499 to GLOW at $999, so modulation is not a premium feature within the range.
What matters more than modulation
Whether the device crosses the motor threshold at all is the first question, since a device that never produces a contraction is not doing muscle work regardless of how cleverly it varies anything.
On PureLift the threshold is crossed at level three, with levels one and two running nanocurrent and microcurrent below it.
After that, the variable that decides your result is how often you actually use the device, and Kavanagh 2012 got its measured increase in zygomaticus major thickness from 12 weeks of repeated sessions (10.1111/jocd.12007).
Three minutes per side, four times a week, for three months will move the needle further than any waveform argument, on any brand.